Responding to the New Era of Value-based Care with Comprehensive Medication Management

Ready your Future Today with the 2017 / 2018 A3 Collaborative

AIMM is partnering with Apexus, the HRSA-designated Prime Vendor for the 340B Drug Pricing Program, and ASHP (American Society of Health-System Pharmacists) to offer the 2017/2018 National A3 Collaborative, a year-long learning experience to help health care providers succeed in the new era of value-based payment programs.

As a member of the 2017/2018 National A3 Collaborative, organizations will participate in a 12-month transformational experience that will establish a new strategic capability. An implementation team will be formed by each organization to rapidly put in place a working medication management program, or to focus on accelerating the scale and spread of one already in place.

For more details:

List of Participating Organizations for the National A3 Collaborative Spring Cohort

Participating organizations will deliver three results through value-defined initiatives:

  1. Population management: adopt a population health management strategy that demonstrates value to improving health outcomes, providing better care and demonstrating cost effectiveness,
  2. Integrated services: install the clinical pathways that support the integration of primary care and comprehensive medication management services, and
  3. Performance story: produce evidence-based results for quality improvement and strategic business conversations.

Participating Organizations will have access to:

  • Resources and tools to build the business case for an effective CMM strategy focusing on improved health outcomes, better patient care, and cost effectiveness.
  • AIMM’s proven action learning method, which uses effective leadership skills and quality improvement practices to rapidly identify strategies to build, improve processes and deliver CMM services.
  • Individualized support from a program development coach for technical assistance and consultancy on your organization’s CMM value-based initiative.
  • Monthly webinars with national network of peers and access to best practice models for replication.
  • Live learning events* offering an energizing experience with subject matter experts. Harvest learnings from peers who are pursuing a shared vision and urgency to attain transformational goals.
    *A3 Collaborative Participation fee does not include travel expenses to live learning events.

A3 Collaborative Participation Fee: 

Participation in this dynamic, leading edge collaborative network is offered at a cost of $9,000 for the year, plus the cost of team member travel to in-person events. A3 Collaborative partner, Apexus, is offering scholarship funding to organizations to offset a portion of the costs of participating in the learning collaborative. All organizations are invited to apply for a $6,000 scholarship to cover part of the participation fees. Organizations will be responsible for the remaining $3,000 fee, which is invoiced upon notification of a scholarship award. Scholarship and participation fees cover participation for the 2017 / 2018 Collaborative cycle (Fall Cohort), which ends September 30, 2018.

For questions or to learn more contact AIMM at

Joining AIMM, you become part of a growing body of evidence demonstrating the value for comprehensive medication management services, which is critical during an era when our U.S. health care system transforms to quality payment models.